Page last updated: 2024-08-25

clarithromycin and fropenem

clarithromycin has been researched along with fropenem in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Fujioka, T; Hasegawa, M; Igari, J; Kobayashi, I; Matsuzaki, K; Nasu, M; Saika, T; Saionji, K	1
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K	1
Mitsuno, Y; Yoshida, H	1
Amitani, R; Kimoto, T; Suzuki, K; Tanaka, E; Tsuyuguchi, K	1
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y	1
Kobayashi, C; Sakai, T; Shinohara, M	1
Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T	1
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y	1

Trials

1 trial(s) available for clarithromycin and fropenem

Article	Year
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome	2002

Article

Year

[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].

Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome

2002

Other Studies

7 other study(ies) available for clarithromycin and fropenem

Article	Year
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Lactams	1998
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:8 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1	1999
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2002, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Humans; Lactams; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous	2002
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl B Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors	2001
Mycobacterium peregrinum infection in a patient with AIDS. Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; Humans; Imipenem; Lactams; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; RNA, Viral	2005
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA]. Kekkaku : [Tuberculosis], 2016, Volume: 91, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome	2016
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA	2020